Trends in Pharmacological Sciences
Volume 12, 1991, Pages 343-349
TIPS reviewProto-oncogene transcription factors and epilepsy
References (46)
- et al.
Cell
(1988) - et al.
Curr. Opin. Struct. Biol.
(1991) - et al.
J. Biol. Chem.
(1985) Neuron
(1989)- et al.
Trends Neurosci.
(1989) - et al.
Brain Res.
(1990) Brain Res.
(1990)- et al.
Mol. Brain Res.
(1988) Trends Neurosci.
(1988)- et al.
Exp. Neurol.
(1980)
Neuropharmacol.
(1988)
Brain Res.
(1988)
Exp. Neurol.
(1988)
Mol. Brain Res.
(1987)
BioEssays
(1987)
Annu. Rev. Neurosci.
(1991)
Science
(1985)
Nature
(1986)
Science
(1991)
Science
(1987)
J. Neurosci. Res.
(1989)
Cited by (235)
20(S)-ginsenoside Rh2 inhibits angiotensin-2 mediated cardiac remodeling and inflammation associated with suppression of the JNK/AP-1 pathway
2023, Biomedicine and PharmacotherapyLysM-positive neurons drive Tuberous Sclerosis Complex (TSC)-associated brain lesions
2022, Cellular SignallingDevelopment and validation of chemical kindling in adult zebrafish: A simple and improved chronic model for screening of antiepileptic agents
2020, Journal of Neuroscience MethodsCitation Excerpt :Thec-fos expression is considered as a marker of neuronal activity in the mammalian nervous system. c-fos is a proto-oncogene that encodes a DNA binding phosphoprotein Fos which forms a dimeric complex with Jun protein and activates transcription factor activator protein-1 (Morgan and Curran, 1991; Jensen et al., 1993). Studies have shown in vitro activation of c-fos on the depolarization of neural cells (Labiner et al., 1993).
Spontaneous and light-induced lateralization of immediate early genes expression in domestic chicks
2019, Behavioural Brain Research
Copyright © 1991 Published by Elsevier Ltd.